Tag: Diabetes: Type II
Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
Lower composite incidence of macrovascular events, lower incidence of coronary artery disease at 5 years
Cases Show Periodic Fasting May Cut Medication Use in T2DM
Discontinuation of insulin, other diabetes medications seen in case series of three patients
High Circulating Prolactin Level Inversely Linked to T2DM Risk
Inverse link for total plasma prolactin, type 2 diabetes risk was not altered by menopausal status
ADA, EASD Issue New Recommendations for T2DM
Additional focus on lifestyle management, self-management education and support emphasized
Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria
Albiglutide Beats Placebo for Cardiovascular Events in T2DM
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Genetics May Identify Type 2 Diabetes Subtypes
Five clusters of T2DM loci and traits, each with distinct tissue-specific enhancer enrichment, identified
HbA1c Variability Is a Strong Predictor of Mortality in T2DM
HbA1c variability is a powerful, independent measure, regardless of how it is measured
Higher Aldosterone Levels Tied to Incident Type 2 Diabetes Risk
Racial/ethnic differences seen in the association of aldosterone with incident type 2 diabetes
FDA: Common Diabetes Meds Tied to Serious Genital Infection
Sodium-glucose cotransporter-2 inhibitors linked to 12 cases of Fournier's gangrene
